MA-PRECISELY
1.12.2022 12:01:41 CET | Business Wire | Press release
Precisely, the global leader in data integrity, today announced it is working with Amazon Web Services (AWS) on its AWS Mainframe Modernization service. The integration offers real-time replication of mainframe data to AWS leveraging Precisely Connect, allowing customers to securely and efficiently migrate data, as well as access mainframe data on AWS for more powerful analytics.
This new scope of work delivers a mainframe modernization solution to the market that allows customers to replicate mainframe data onto AWS with zero downtime. The functionality allows customers to build resilient, high-performance data pipelines that connect data from their mainframe databases to AWS services like Amazon Relational Database Service (Amazon RDS), Amazon Aurora, Amazon Simple Storage Service (Amazon S3), Amazon EMR, Amazon Managed Streaming for Apache Kafka (MSK), Amazon Redshift, Snowflake on AWS, and more. By accelerating access to mainframe data on AWS, businesses can get mainframe migration projects done on time and on budget, all while extending the value of mission-critical, and high investment, mainframe systems. The integration solution works within a business’s existing architecture, allowing teams to future-proof solutions and be flexible when introducing new applications and use cases.
Customers that have already begun taking advantage of these joint capabilities include AAA Life Insurance:
“Our customers rely on us to provide financial protection for their loved ones, and with over 1,500,000 active policies, central to success is real-time access to trusted data across multiple sources. This includes mainframe systems - which are notoriously challenging to integrate effectively,” said Steven Hinzmann, Manager of Application Development at AAA Life Insurance. “Precisely Connect allows us to quickly and easily access vast volumes of historical business and customer data, which is then replicated to the AWS environment where it can be leveraged for advanced analytics. The combination of Precisely’s rich heritage in handling mainframe data with AWS’s cloud platform has been unbeatable for allowing us to innovate and drive the best possible customer experience."
“Data is the lifeblood of the digital economy and the pipelines that carry it are essential to a business’s IT infrastructure,” said Eric Yau, Chief Operating Officer at Precisely. “Together with AWS, we can help our customers to maximize their data and investments - unlocking the true potential of their critical data assets to power their business by making critical data assets available for AWS and for advanced analytics.”
“AWS and Precisely empower our customers to build trust in their data,” said Bill Platt, General Manager for Migration Services at AWS. “By integrating data from complex mainframe systems directly onto AWS, customers can rely on their data to be the driving force of confident analytics, and ensure they are deriving maximum value from their infrastructure investments.”
Learn more about the work between Precisely and AWS here, or visit Precisely at AWS re:Invent to speak with its team of data integrity experts.
About Precisely
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221201005545/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on ALYFTREK® at European Cystic Fibrosis Conference5.6.2026 18:00:00 CEST | Press release
- ALYFTREK Phase 3 data on children with cystic fibrosis ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including F/F and F/MF shows 65% reached sweat chloride levels of <30 mmol/L; Vertex on track to initiate global regulatory submissions in first half of 2026 - - Long-term 96-week interim analyses from two open-label extension studies demonstrate positive safety and efficacy profile of ALYFTREK in people with cystic fibrosis ages 6 and older -- Phase 3 data on TRIKAFTA® in children 1 to <2 years also presented; Vertex has initiated global regulatory submissions - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 13:00:00 CEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 12:41:00 CEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.6.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to seventeen newly hired non-executive employees. The equity awards were granted on June 1, 2026 and consisted of options to purchase an aggregate of 157,000 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 74,700 shares. The options have an exercise price per share equal to $14.19, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restrict
Renewable Electricity, Soft Wheat Flour From Regenerative Agriculture, Initiatives to Support Local Communities: Barilla Shares These and Other Projects in “Stories of Sustainability.”5.6.2026 10:00:00 CEST | Press release
Barilla continues to advance its commitment to tastier products with less sugar and salt;An investment of 30 million euros in 2025 to quadruple photovoltaic capacity across plants, as part of a €168 million five-year plan focused on energy efficiency, renewable energy and sustainable water management.Barilla continues to expand regenerative agriculture practices across its global value chain, with over 816,000 tons of raw materials sourced through the Barilla Sustainable Farming program.4,000 tons of products donated worldwide and €2 million allocated to social causes in 2025, supporting communities across Barilla’s global footprint through food donations and social initiatives. A slimmer Tagliatelle pack that saves 150 tons of cardboard and cuts transport-related CO₂ emissions by 20%1; ready-made sauce jars made with around 65% recycled glass; the progressive scaling of regenerative agriculture practices across Barilla’s value chain and initiatives supporting inclusion and equal oppor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom